CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 178 enrolled
Drug / intervention
Continuous Glucose Monitoring (CGM)device
Likely dose
FreeStyle Libre 2 continuous glucose monitor worn for up to 7 monthsAI-extracted
Key inclusion· 9
  • ✓Age over 18 years
  • ✓Type 2 diabetes diagnosis
  • ✓HbA1c between 7.5-11.5% documented within 60 days prior to consent
  • ✓Stable diabetes medication regimen and lifestyle patterns within ~90 days prior to consent
Key exclusion· 8
  • ✕Type 1 diabetes
  • ✕Currently using insulin pump or >3 insulin injections per day or bolus insulin with every meal
  • ✕Currently following very low-carbohydrate eating pattern
  • ✕Currently using personal CGM or plans to use CGM during study

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05516797
NCT05516797N/ACompleted
CompareCT.gov

Continuous Glucose Monitoring Versus Blood Glucose Monitoring to Optimize Glycemic Outcomes in People With Type 2 Diabetes Following the Virta Treatment Program" (IGNITE: Impact of Glucose moNitoring and nutrItion on Time in rangE Study)

HealthPartners Institute·interventional·Posted Aug 26, 2022·Updated Mar 26, 2025

In Brief

A clinical study evaluating Continuous Glucose Monitoring (CGM) for Type 2 Diabetes. Completed, enrolled 178 participants across 1 site.

Detailed Summary

The purpose of this study is to learn whether there is a difference in the amount of time glucose (blood sugar) stays within a target range (glucose 70 - 180 mg/dl) when using either continuous glucose monitoring (CGM) or fingerstick blood glucose monitoring (BGM) in people with Type 2 diabetes who participate in the Virta Treatment program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
CollaboratorsVirta Health, Abbott Diabetes Care

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 26, 2022
Enrollment StartSep 22, 2022
Primary CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 3.9 years ago

Interventions

Continuous Glucose Monitoring (CGM)device

Use of CGM (FreeStyle Libre 2) compared to BGM for glucose monitoring